Vericel Corp. (VCEL) intrinsic value & 10-year financials

Vericel Corp. (VCEL) has a Graham intrinsic value of $10.63 per share. At $40.13 on Oct 17, 2026, the stock trades 278% above that value. Over the last 10 fiscal years revenue grew 19.8% a year to $276.3M, with an average return on invested capital of -17.0%.

Graham intrinsic value
$10.63
Share price (Oct 17, 2026)
$40.13
Price vs Graham value
278% above
Market cap
$2.1B
Revenue (FY2025)
$276.3M
Revenue growth (10-yr CAGR)
19.8%
ROIC (10-yr avg)
-17.0%
Free cash flow (FY2025)
$24.7M

VCEL 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $276.3M $16.5M $0.32 $24.7M 4.0% 3.3%
FY2024 $237.2M $10.4M $0.20 -$5.8M 1.9% 1.6%
FY2023 $197.5M -$3.2M -$0.07 $15.3M -3.3% -3.1%
FY2022 $163.7M -$16.7M -$0.35 $10.1M -10.4% -10.2%
FY2021 $153.1M -$7.5M -$0.16 $21.1M -5.1% -5.2%
FY2020 $122.0M $2.9M $0.06 $14.9M 1.9% 1.7%
FY2019 $117.8M -$9.7M -$0.22 -$9.8M -9.5% -10.6%
FY2018 $90.9M -$8.1M -$0.20 -$3.1M -4.3% -6.3%
FY2017 $62.8M -$17.3M — -$14.7M -23.9% -63.4%
FY2016 $54.4M -$19.6M — -$21.3M -35.4% -77.9%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Vericel Corp is a consistent compounder, expanding top-line revenue at 19.8% annually over the past decade.

Vericel Corp has historically struggled to out-earn its cost of capital, averaging just -17.0% ROIC.

Vericel Corp capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Vericel Corp is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $10.63 per share.

VCEL stock: frequently asked questions

What is the intrinsic value of Vericel Corp. (VCEL) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, VCEL's intrinsic value is about $10.63 per share.

Is VCEL stock undervalued?

At $40.13 (close on Oct 17, 2026), VCEL trades 278% above its Graham value of $10.63. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Vericel Corp. grown?

Revenue went from $54.4M in fiscal 2016 to $276.3M in fiscal 2025, a compound annual growth rate of 19.8%. Net income was $16.5M in fiscal 2025.

Does Vericel Corp. generate free cash flow?

Vericel Corp. generated $24.7M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 5 of the last 10 reported years.

What is VCEL's return on invested capital?

Average ROIC over the last 10 fiscal years was -17.0%, and average return on equity was -17.9%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this VCEL data come from?

From Vericel Corp.'s annual 10-K filings on SEC EDGAR. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar biological products stocks